Nima Melzer

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Contribution of platelets to tumour metastasis

Therapy for Cancer-Related Thromboembolism

Prevention of VTE in Nonsurgical Patients

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Thrombosis and cancer

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Management of glioblastoma: State of the art and future directions

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

Anticoagulation for people with cancer and central venous catheters

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

CERTIFY: Prophylaxis of venous thromboembolism in patients with severe renal insufficiency

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY

Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study

Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer